What does the future of Anti-Aging Medicine hold for us?
Neolife
24 de April de 2018
Age is the main risk factor for most of the chronic diseases that afflict us in that last third of our lives. The first step
Age is the main risk factor for most of the chronic diseases that afflict us in that last third of our lives. The first step
Changes in our microbiota have recently been linked to the onset of neurodegenerative, autoimmune and cardiovascular diseases. Microbiota is the community of bacteria living as
The star treatment -metformin- is ineffective in up to 20% of patients due to a genetic mutation, forcing treatment to be personalized. Dr. Florez (Head
A study has shown that hypothyroidism, even at a subclinical level, is associated with an increased occurrence of sudden death events and overall mortality. The
There are studies underway that focus on anti-ageing drugs -such as metformin and nicotinamide adenine (NAD+)- as well as the molecules that elongate telomeres -such
The medicine of the future will be Preventive, Predictive, Proactive and Personalized. And furthermore, to ensure continuity in patient care, treatment must be Pleasant. In
A study in the journal Jama Psychiatry demonstrates how hormone therapy may prevent the depressive symptoms that often appear during menopause. In addition, an article
Statins not only decrease the number of deaths caused by cardiovascular diseases, but they are also likely to protect women from the occurrence of breast
Aging, longevity, eternal life and eternal youth have been concepts that have deeply worried society since ancient times. Today, in the XXI century this way
A recent study demonstrates the unreliability of using conventional measures to assess the presence of obesity in menopausal women. In the study, published in the
A recent study has demonstrated that Sildenafil (Viagra) may prevent coronary stents which have been implanted following ischemic heart disease from becoming obstructed. In the
A new handheld device – called MassSpec – enables the user to distinguish between healthy tissues and malignant tumours quickly and reliably. The device uses
In the absence of a drug to stop the progression of the disease the most effective weapon at present is prevention. There are a number
A publication in the prestigious Annals of Oncology journal states that this measure is most effective after patients who are losing weight or quitting smoking.
A recent article published in Medpage subjects observational studies to harsh criticism. The author, Larry Husten, laments that some observational studies have so such media
|
|